Logo image of HRPK.DE

7C SOLARPARKEN AG (HRPK.DE) Stock Fundamental Analysis

FRA:HRPK - Deutsche Boerse Ag - DE000A11QW68 - Common Stock - Currency: EUR

1.832  0 (-0.11%)

Fundamental Rating

3

Overall HRPK gets a fundamental rating of 3 out of 10. We evaluated HRPK against 20 industry peers in the Independent Power and Renewable Electricity Producers industry. The financial health of HRPK is average, but there are quite some concerns on its profitability. HRPK has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year HRPK was profitable.
HRPK had a positive operating cash flow in the past year.
In the past 5 years HRPK has always been profitable.
Each year in the past 5 years HRPK had a positive operating cash flow.
HRPK.DE Yearly Net Income VS EBIT VS OCF VS FCFHRPK.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

1.2 Ratios

HRPK has a worse Return On Assets (0.08%) than 60.00% of its industry peers.
With a Return On Equity value of 0.21%, HRPK is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
HRPK has a worse Return On Invested Capital (1.56%) than 65.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for HRPK is in line with the industry average of 4.87%.
Industry RankSector Rank
ROA 0.08%
ROE 0.21%
ROIC 1.56%
ROA(3y)2.05%
ROA(5y)1.85%
ROE(3y)5.16%
ROE(5y)4.85%
ROIC(3y)3.92%
ROIC(5y)3.5%
HRPK.DE Yearly ROA, ROE, ROICHRPK.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 0.71%, HRPK is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
HRPK's Profit Margin has declined in the last couple of years.
HRPK has a Operating Margin (15.58%) which is in line with its industry peers.
In the last couple of years the Operating Margin of HRPK has declined.
Industry RankSector Rank
OM 15.58%
PM (TTM) 0.71%
GM N/A
OM growth 3Y-20.96%
OM growth 5Y-13.74%
PM growth 3Y-65.62%
PM growth 5Y-47.74%
GM growth 3YN/A
GM growth 5YN/A
HRPK.DE Yearly Profit, Operating, Gross MarginsHRPK.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HRPK is still creating some value.
Compared to 1 year ago, HRPK has about the same amount of shares outstanding.
Compared to 5 years ago, HRPK has more shares outstanding
Compared to 1 year ago, HRPK has a worse debt to assets ratio.
HRPK.DE Yearly Shares OutstandingHRPK.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
HRPK.DE Yearly Total Debt VS Total AssetsHRPK.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

Based on the Altman-Z score of 0.62, we must say that HRPK is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.62, HRPK is doing worse than 65.00% of the companies in the same industry.
HRPK has a debt to FCF ratio of 5.63. This is a neutral value as HRPK would need 5.63 years to pay back of all of its debts.
The Debt to FCF ratio of HRPK (5.63) is better than 85.00% of its industry peers.
A Debt/Equity ratio of 0.85 indicates that HRPK is somewhat dependend on debt financing.
HRPK has a Debt to Equity ratio (0.85) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 5.63
Altman-Z 0.62
ROIC/WACC0.41
WACC3.82%
HRPK.DE Yearly LT Debt VS Equity VS FCFHRPK.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

HRPK has a Current Ratio of 1.48. This is a normal value and indicates that HRPK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.48, HRPK is in line with its industry, outperforming 55.00% of the companies in the same industry.
HRPK has a Quick Ratio of 1.46. This is a normal value and indicates that HRPK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.46, HRPK is in line with its industry, outperforming 55.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.46
HRPK.DE Yearly Current Assets VS Current LiabilitesHRPK.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2

3. Growth

3.1 Past

The earnings per share for HRPK have decreased strongly by -93.52% in the last year.
Measured over the past years, HRPK shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -47.56% on average per year.
HRPK shows a decrease in Revenue. In the last year, the revenue decreased by -9.37%.
HRPK shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.97% yearly.
EPS 1Y (TTM)-93.52%
EPS 3Y-65.73%
EPS 5Y-47.56%
EPS Q2Q%-108.55%
Revenue 1Y (TTM)-9.37%
Revenue growth 3Y4.02%
Revenue growth 5Y7.97%
Sales Q2Q%-4.3%

3.2 Future

Based on estimates for the next years, HRPK will show a small growth in Earnings Per Share. The EPS will grow by 1.66% on average per year.
The Revenue is expected to decrease by -2.94% on average over the next years.
EPS Next Y52.63%
EPS Next 2Y21.4%
EPS Next 3Y1.66%
EPS Next 5YN/A
Revenue Next Year5.14%
Revenue Next 2Y3.66%
Revenue Next 3Y2.42%
Revenue Next 5Y-2.94%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
HRPK.DE Yearly Revenue VS EstimatesHRPK.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 20M 40M 60M 80M
HRPK.DE Yearly EPS VS EstimatesHRPK.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.05 0.1 0.15 0.2 0.25

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 183.20, HRPK can be considered very expensive at the moment.
Based on the Price/Earnings ratio, HRPK is valued a bit more expensive than 65.00% of the companies in the same industry.
HRPK is valuated expensively when we compare the Price/Earnings ratio to 26.41, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 12.39, which indicates a correct valuation of HRPK.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HRPK indicates a somewhat cheap valuation: HRPK is cheaper than 80.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 33.87, HRPK is valued rather cheaply.
Industry RankSector Rank
PE 183.2
Fwd PE 12.39
HRPK.DE Price Earnings VS Forward Price EarningsHRPK.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

HRPK's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. HRPK is cheaper than 80.00% of the companies in the same industry.
HRPK's Price/Free Cash Flow ratio is rather cheap when compared to the industry. HRPK is cheaper than 95.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 3.4
EV/EBITDA 6.58
HRPK.DE Per share dataHRPK.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)3.48
PEG (5Y)N/A
EPS Next 2Y21.4%
EPS Next 3Y1.66%

3

5. Dividend

5.1 Amount

HRPK has a Yearly Dividend Yield of 3.59%.
HRPK's Dividend Yield is a higher than the industry average which is at 3.33.
Compared to an average S&P500 Dividend Yield of 2.39, HRPK pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.59%

5.2 History

The dividend of HRPK decreases each year by -4.82%.
Dividend Growth(5Y)-4.82%
Div Incr Years0
Div Non Decr Years0
HRPK.DE Yearly Dividends per shareHRPK.DE Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

HRPK pays out 1427.94% of its income as dividend. This is not a sustainable payout ratio.
DP1427.94%
EPS Next 2Y21.4%
EPS Next 3Y1.66%
HRPK.DE Yearly Income VS Free CF VS DividendHRPK.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
HRPK.DE Dividend Payout.HRPK.DE Dividend Payout, showing the Payout Ratio.HRPK.DE Dividend Payout.PayoutRetained Earnings

7C SOLARPARKEN AG

FRA:HRPK (8/12/2025, 3:35:34 PM)

1.832

0 (-0.11%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryIndependent Power and Renewable Electricity Producers
Earnings (Last)05-28 2025-05-28
Earnings (Next)09-17 2025-09-17
Inst Owners9.5%
Inst Owner ChangeN/A
Ins Owners7.45%
Ins Owner ChangeN/A
Market Cap149.07M
Analysts42.22
Price Target3.67 (100.33%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.59%
Yearly Dividend0.08
Dividend Growth(5Y)-4.82%
DP1427.94%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 183.2
Fwd PE 12.39
P/S 2.36
P/FCF 3.4
P/OCF 3.03
P/B 0.68
P/tB 0.69
EV/EBITDA 6.58
EPS(TTM)0.01
EY0.55%
EPS(NY)0.15
Fwd EY8.07%
FCF(TTM)0.54
FCFY29.42%
OCF(TTM)0.61
OCFY33.04%
SpS0.78
BVpS2.7
TBVpS2.65
PEG (NY)3.48
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.08%
ROE 0.21%
ROCE 2.07%
ROIC 1.56%
ROICexc 1.86%
ROICexgc 1.88%
OM 15.58%
PM (TTM) 0.71%
GM N/A
FCFM 69.32%
ROA(3y)2.05%
ROA(5y)1.85%
ROE(3y)5.16%
ROE(5y)4.85%
ROIC(3y)3.92%
ROIC(5y)3.5%
ROICexc(3y)4.29%
ROICexc(5y)3.86%
ROICexgc(3y)4.32%
ROICexgc(5y)3.89%
ROCE(3y)5.2%
ROCE(5y)4.65%
ROICexcg growth 3Y-21.25%
ROICexcg growth 5Y-13.6%
ROICexc growth 3Y-21.3%
ROICexc growth 5Y-13.46%
OM growth 3Y-20.96%
OM growth 5Y-13.74%
PM growth 3Y-65.62%
PM growth 5Y-47.74%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 5.63
Debt/EBITDA 4.02
Cap/Depr 14.69%
Cap/Sales 8.52%
Interest Coverage 1.81
Cash Conversion 105.86%
Profit Quality 9725.06%
Current Ratio 1.48
Quick Ratio 1.46
Altman-Z 0.62
F-Score5
WACC3.82%
ROIC/WACC0.41
Cap/Depr(3y)21.59%
Cap/Depr(5y)26.7%
Cap/Sales(3y)10.56%
Cap/Sales(5y)13.97%
Profit Quality(3y)3432.97%
Profit Quality(5y)2234.89%
High Growth Momentum
Growth
EPS 1Y (TTM)-93.52%
EPS 3Y-65.73%
EPS 5Y-47.56%
EPS Q2Q%-108.55%
EPS Next Y52.63%
EPS Next 2Y21.4%
EPS Next 3Y1.66%
EPS Next 5YN/A
Revenue 1Y (TTM)-9.37%
Revenue growth 3Y4.02%
Revenue growth 5Y7.97%
Sales Q2Q%-4.3%
Revenue Next Year5.14%
Revenue Next 2Y3.66%
Revenue Next 3Y2.42%
Revenue Next 5Y-2.94%
EBIT growth 1Y-61.56%
EBIT growth 3Y-17.78%
EBIT growth 5Y-6.86%
EBIT Next Year217.14%
EBIT Next 3Y54.28%
EBIT Next 5Y36.96%
FCF growth 1Y28.37%
FCF growth 3Y23.7%
FCF growth 5Y19.91%
OCF growth 1Y9.4%
OCF growth 3Y7%
OCF growth 5Y12.06%